Evidence synthesis
Epidemiology
Biostatistics
Community medicine

Since March 2015 Alexander Tsertsvadze is a Senior Research Fellow with the Communicable Disease Control Evidence and Epidemiology (CDCE2) team within the Population and Evidence Based Technologies (PET), Division of Health Sciences, Warwick Medical School, at University of Warwick. He is a clinical epidemiologist, methodologist, and expert in evidence-based synthesis (e.g., systematic reviews, meta-analysis, and other synthesis reports) with more than 12 years of experience acquired in the academic world. His main focus is the use of epidemiological methods in evidence synthesis.

Alexander has been actively involved in the conduct of comparative effectiveness reviews and health technology assessments across different clinical areas and methodological topics. One of his main responsibilities has been to ensure methodological soundness, rigour, and high reporting quality of evidence synthesis reports. During his career, Alexander has collaborated with several key national or international organisations in North America and the UK such as the National Institute for Health and Care Excellence (NICE), Canadian Agency for Drugs and Technologies in Health (CADTH), Institute of Medicine (IOM), Cochrane, and American College of Physicians.

Alexander has published in high impact medical journals and co-authored chapters for the book 'Randomized Clinical Trials of Nonpharmacological Treatments' (Taylor and Francis Group 2012) and the AHRQ's Methods Guide for Effectiveness and Comparative Effectiveness Reviews. His most recent work includes the methodology and international harmonization of updating of systematic reviews. The Cochrane adopted and incorporated into their Handbook of Systematic Reviews the definition for 'updating' of a systematic review proposed in Alexander's paper published in the Lancet. As of 2011, Alexander has served as an associate editor of a newly established journal Systematic Reviews (BioMed Central Publishing Group), whose editorial board consists of many world-renowned health scientists.